Finland· FI-REL-REL42499

Rivastigmin Ratiopharm

A rivastigmine product containing rivastigmine, registered in Finland by ratiopharm GmbH. The same ATC class is registered in 18 of our 19 countries.

ATC N06DA03

Checked against Fimea (Finland) on September 27, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about rivastigmineAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Rivastigmine is registered in 18 of 19 countries.

Countries holding a registration under ATC N06DA03 (rivastigmine), each read from that country’s own register.

This record: Finland, from Fimea (Finland)
11 of them publish a price we can compare per daily dose

Search rivastigmine products by name

Rivastigmine · ATC N06DA03

18 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Italyprice
Netherlands
Norwayprice
Polandprice
Spainprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of rivastigmine costs, country by country.

Normalised to the WHO defined daily dose (9 mg), the median price runs from $0.042 in Czechia to $2.19 in Italy — a ×52 gap.

3 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Rivastigmine · price per daily dose (9 mg)

USD · FX 28 Sept 2026

IT Italy$2.19
CH Switzerland$1.33
CZ Czechia$0.042

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Fimea (Finland)

Active substance: Rivastigmine
Manufacturer: ratiopharm GmbH
Country: Finland (FI)
ATC code: N06DA03
ATC class: Rivastigmine
Defined daily dose: 9 mg, O
Reimbursed: Not published by this register
Source register: Fimea (Finland)
Last checked: September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

235 interactions on record for rivastigmine.

Graded by severity as the source publishes them — 8 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check rivastigmine against other medicines How interaction checks work

Rivastigmine · interactions on record

235 records

8 severe
166 moderate
59 info

Most severe, free to view

OzanimodL04AA38severe
SiponimodL04AA42severe
OzanimodL04AE02severe
SiponimodL04AE03severe

2 more interactions with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Rivastigmine in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All rivastigmine products

Authorised across Europe · EMA

The same active substance is authorised in 21 EEA countries. Names it is sold under:

Austria · Nimgista, Rivagelan
Belgium · Rivastigmin Sandoz, Rivastigmine Viatris
Bulgaria · Ридаксин
Germany · Demelora, Rivastigmin
Denmark · Rigmin, Rivastigmin Orion
Spain · Alzerta, Alzerta Dos Por Semana
France · Rivastigmine Arrow, Rivastigmine Biogaran
United Kingdom (Northern Ireland) · Almuriva, Alzest
Greece · Alapril, Balaxon
Iceland · Exelon, Nimvastid
Italy · Demelora, Rivastigmina Aurobindo
Liechtenstein · Exelon, Rivastigmine 1 A Pharma
Malta · Rivastigmine Aurobindo
Netherlands · Ristidic, Rivastgimine Neuraxpharm
Norway · Exelon, Nimvastid
Poland · Atmina, Evertas
Portugal · Nervopan, Rivastigmina Alter
Romania · Evertas, Ridaxin
Sweden · Rigmin, Rivastigmin Orion
Slovenia · Rivastigmin Teva, Rivastigmin Teva B.V.
Slovakia · Ristidic

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/fb4368ae-6532-45c3-8072-29dbcf13d7fe
GET /v1/drugs/fb4368ae-6532-45c3-8072-29dbcf13d7fe?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": "9.5",
  "form": "depotlaastari",
  "route": null,
  "ddd_unit": "mg",
  "strength": "9.5 mg / 24 h",
  "atc_label": "rivastigmiini",
  "ma_number": "31003",
  "auth_status": "Myyntilupa peruuntunut",
  "eu_ma_number": null,
  "fimea_rel_id": "REL42499",
  "authorised_at": "2013-11-04"
}

API reference MCP server Plans

See everything about rivastigmine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console